Epoprostenol-associated pneumonitis: Diagnostic use of a T-cell proliferation assay

Journal of Heart and Lung Transplantation

Volumn 29, Issue 9, 2010, Pages 1071-1075

  Kudelko, Kristina T ^a,b   Nadeau, Kari ^c   Leung, Ann N ^c   Liu, Juliana ^b   Haddad, François ^b,c   Zamanian, Roham T ^a,b   De Jesus Perez, Vinicio ^b  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c STANFORD UNIVERSITY   (United States)

Author keywords

Hypertension; Interstitial; Pneumonia; Pprostaglandins; Pulmonary

Indexed keywords

AMIODARONE; DILUENT; DIURETIC AGENT; FUROSEMIDE; ILOPROST; METHYLPREDNISOLONE; PREDNISONE; PROSTACYCLIN; PROSTAGLANDIN E1; SILDENAFIL; SODIUM CHLORIDE; UNIPROST; ANTIARRHYTHMIC AGENT; ANTIHYPERTENSIVE AGENT;

ADULT; ANAMNESIS; ARTICLE; CASE REPORT; CD3+ T LYMPHOCYTE; CELL ASSAY; CELL ISOLATION; CELL STIMULATION; COMPUTER ASSISTED TOMOGRAPHY; DISEASE SEVERITY; DRUG INDUCED DISEASE; DRUG INDUCED PNEUMONITIS; DYSPNEA; EPOPROSTENOL ASSOCIATED PNEUMONITIS; FEMALE; HEART RIGHT VENTRICLE FAILURE; HUMAN; INTENSIVE CARE UNIT; INTERSTITIAL PNEUMONIA; LEG EDEMA; LUNG INTERSTITIUM; LUNG LAVAGE; LYMPHOCYTE PROLIFERATION; OXYGEN THERAPY; PERIPHERAL BLOOD MONONUCLEAR CELL; PNEUMONIA; PRIORITY JOURNAL; PULMONARY HYPERTENSION; T LYMPHOCYTE; TRANSTHORACIC ECHOCARDIOGRAPHY; TREATMENT RESPONSE; CHEMICALLY INDUCED DISORDER; DRUG INTERACTION; ECHOGRAPHY; IMMUNOLOGY; LUNG DISEASE; LYMPHOCYTE ACTIVATION;

ADULT; AMIODARONE; ANTI-ARRHYTHMIA AGENTS; ANTIHYPERTENSIVE AGENTS; DRUG INTERACTIONS; EPOPROSTENOL; FEMALE; HUMANS; HYPERTENSION, PULMONARY; LUNG DISEASES; LYMPHOCYTE ACTIVATION; PNEUMONIA; PREDNISONE; T-LYMPHOCYTES;

EID: 79952112576     PISSN: 10532498     EISSN: 15573117     Source Type: Journal    
DOI: 10.1016/j.healun.2010.04.023     Document Type: Article

References (17)

1. Barst RJ, Rubin LJ, Long WA et al. A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension. N Engl J Med 1996;334:296-301. (Pubitemid 26033085)
2. Chin KM, Channick RN, de Lemos JA, Kim NH, Torres F, Rubin LJ. Hemodynamics and epoprostenol use are associated with thrombocytopenia in pulmonary arterial hypertension. Chest 2009;135:130-6.
3. Gugnani MK, Pierson C, Vanderheide R, Girgis RE. Pulmonary edema complicating prostacyclin therapy in pulmonary hypertension associated with scleroderma: a case of pulmonary capillary hemangiomatosis. Arthritis Rheum 2000;43:699-703. (Pubitemid 30394964)
4. Palmer SM, Robinson LJ, Wang A, Gossage JR, Bashore T, Tapson VF. Massive pulmonary edema and death after prostacyclin infusion in a patient with pulmonary veno-occlusive disease. Chest 1998;113:237-40. (Pubitemid 28044953)
5. Naisbitt DJ. Drug hypersensitivity reactions in skin: understanding mechanisms and the development of diagnostic and predictive tests. Toxicology 2004;194:179-96. (Pubitemid 37542452)
6. Morimatsu H, Goto K, Matsusaki T et al. Rapid development of severe interstitial pneumonia caused by epoprostenol in a patient with primary pulmonary hypertension. Anesth Analg 2004;99:1205-7. (Pubitemid 39287418)
7. Nguyen KD, Fohner A, Booker JD, Dong C, Krensky AM, Nadeau KC. XCL1 enhances regulatory activities of CD4- CD25(high) CD127(low/-) T cells in human allergic asthma. J Immunol 2009; 181:5386-95.
8. The BAL Cooperative Group Steering Committee. Bronchoalveolar lavage constituents in healthy individuals, idiopathic pulmonary fibrosis, and selected comparison group. Am Rev Respir Dis 1990;141: S169-202.
9. Costabel U, Uzaslan E, Guzman J. Bronchoalveolar lavage in druginduced lung disease. Clin Chest Med 2004;25:25-35. (Pubitemid 38296328)
10. Flieder DB, Travis WD. Pathologic characteristics of drug-induced lung disease. Clin Chest Med 2004;25:37-45. (Pubitemid 38296329)
11. Camus P, Fanton A, Bonniaud P, Camus C, Foucher P. Interstitial lung disease induced by drugs and radiation. Respiration 2004;71:301-26. (Pubitemid 39179164)
12. Ernawati DK, Stafford L, Hughes JD. Amiodarone-induced pulmonary toxicity. Br J Clin Pharmacol 2008;66:82-7. (Pubitemid 351822167)
13. Kharabsheh S, Abendroth CS, Kozak M. Fatal pulmonary toxicity occurring within two weeks of initiation of amiodarone. Am J Cardiol 2002;89:896-8. (Pubitemid 34241479)
14. Kesten S, Dainauskas J, McLaughlin V, Rich S. Development of nonspecific interstitial pneumonitis associated with long-term treatment of primary pulmonary hypertension with prostacyclin. Chest 1999;116:566-9. (Pubitemid 29382147)
15. Ahearn GS, Selim MA, Tapson VF. Severe erythroderma as a complication of continuous epoprostenol therapy. Chest 2002;122:378-80. (Pubitemid 34754191)
16. Pichler WJ, Tilch J. The lymphocyte transformation test in the diagnosis of drug hypersensitivity. Allergy 2004;59:809-20. (Pubitemid 39005820)
17. Nyfeler B, Pichler WJ. The lymphocyte transformation test for the diagnosis of drug allergy: sensitivity and specificity. Clin Exp Allergy 1997;27:175-81. (Pubitemid 27085418)